PANLAR estará presente en la Reunión Anual del American College of Rheumatology que se realizará del 3 al 8 de noviembre de 2017, en el Centro de Convenciones de San Diego en San Diego, California, EE. UU.

Este año, alrededor de 16700 líderes de la industria y profesionales asistirán al ACR ARHP 2017 para reunirse entorno a la reumatología. Los invitamos desde ahora a no perderse nuestras sesiones en el marco de este evento, y a visitar el Booth #: 2417 en donde estaremos ubicados. 

 

 

 

---

 

5T028 ACR:
Pan-American Guidelines on Rheumatic Diseases Update.

About
Session Overview:
To review the current status of Pan-American Guidelines on Rheumatic diseases and seek opportunities of improvementand development for next years.

Learning Objectives:
• Review current pans American recommendations for Chikungunya 
• Explain current pans American recommendations for Biosimilars
  Location: 4
Date: Tuesday, Nov 7 8:30 AM
Duration: 2 hours

5T081 ACR:
ILAR Session: How Rheumatologists Are Trained Around the Globe    

  Session Overview:
ILAR is presenting its annual session to highlight worldwide collaboration. The four global rheumatology leagues will present how rheumatologists are trained in their respective regions. The common elements as well as the differences in training will be presented.

Learning Objectives:
• Identify the different skill sets for teaching rheumatology fellows in various regions of the world 
• Locate the areas where rheumatology training differs significantly 
• Recognize common elements for rheumatology training worldwide
  Location: 31 C
Date: Tuesday, Nov 7 2:30 PM
Duration: 1 hour
 
2:30 PM EULAR
2:45 PM AFLAR
3:00 PM APLAR
3:15 PM PANLAR

---

 

4M069 Study Group:
Challenges for MSUS in Daily Practice in Latin America

  Session Overview:
The assessment and treatment of patients with rheumatic disorders has improved with novel imaging techniques. Although US is part of routine quality care in patients with rheumatic diseases it is not currently a practice in LA, although its contribution  may be of value to better/efficiently allocate resources in a region where they are scarce. As practicing rheumatologists in LA, it is important to be familiar with new concepts in US in order to promote its role in clinical and therapy decision processes for patients with rheumatic disorders. A clinical-based approach will be presented during this session